24/7 Wall St. - Insightful Analysis and Commentary for U.S. and Global Equity Investors Search this site Business Aerospace & Defense Autos Banking & Finance Commodities & Metals Consumer Products Energy Healthcare Industrials Infrastructure Media Retail Services Technology Apps & Software Consumer Electronics Telecom & Wireless Apple Inc. Facebook Google Investing Analyst Upgrades Bankruptcy Buffett Corporate Governance Corporate Performance Dividends and Buybacks Earnings ETFs and Mutual Funds International Markets IPOs and Secondaries Mergers and Acquisitions Personal Finance Rumors Value Investing Economy Energy Government Regulation Healthcare Housing Jobs Special Report Brands and Products Cities Countries States Merck, P&G Lead Dow Stocks Higher Friday By Paul Ausick January 20, 2017 4:01 pm EST Print Email Tweet January 20, 2017: Markets opened higher Friday as investors got little guidance from economic data (there was none) or earnings reports. Equities traded higher in the morning and dipped beginning in the early afternoon, but the three major indexes have stayed in the green all day with about half an hour to go before the closing bell. WTI crude oil for February delivery settled at $52.42 a barrel, up about 2% on the day for a weekly gain of 0.1%. February gold added 0.3% on the day to settle at $1,204.90. Equities were headed for a higher close close shortly before the bell as the DJIA traded up 0.41% for the day, the S&P 500 traded up 0.23%, and the Nasdaq Composite traded up 0.15%. The DJIA stock posting the largest daily percentage gain ahead of the close Friday was Merck & Co. Inc. (NYSE: MRK) which traded up 3.90% at $62.68. The stock’s 52-week range is $47.97 to $65.46. Volume was about 70% higher than the daily average of around 11.2 million shares. The company had no specific news Friday, but rival Bristol-Myers said this morning that it would not see accelerated approval for its lung cancer drug and that leaves Merck in the driver’s seat. The Procter & Gamble Co. (NYSE: PG) traded up 3.24% at $87.44. The stock’s 52-week range is $76.55 to $90.33. Volume was about double the daily average of around 9.3 million shares. The company reported good second-quarter sales growth and raised its fiscal year forecast. International Business Machines Corp. (NYSE: IBM) traded up 1.97% at $170.10. The stock’s 52-week range is $116.90 to $170.62, a new 52-week high posted today. Volume was nearly 3 times the daily average of around 3.5 million shares. The company had no specific news. Exxon Mobil Corp. (NYSE: XOM) traded up about 1.23% at $85.77. The stock’s 52-week range is $73.55 to $95.55. Volume was about 15% above the daily average of around 11.1 million shares. The company had no specific news Friday. Of the Dow 30 stocks, 18 are on track to close higher Friday and 12 are set to close lower. I'm interested in the Newsletter Get Newsletter terms and conditions   By Paul Ausick « 2017 Could Be Another Bust for IPOs Bristol-Myers, Target Sink into Friday’s 52-Week Low Club » Read more: Investing, Dow Jones Industrial Average, market close, International Business Machine... (NYSE:IBM), Merck & Co., Inc. (NYSE:MRK), Procter & Gamble (NYSE:PG), ExxonMobil Corp (NYSE:XOM) Free Daily Newsletter Subscribe Terms & Conditions Sponsors Popular America's Best States to Live In States Where Poverty Is Worse Than You Think American Cities Adding the Most Jobs This Year The Worst CEOs of 2016 States With the Best (and Worst) Schools Recent Rite Aid, J.C. Penney Crash into Friday’s 52-Week Low Club Chevron, Wal-Mart Sink DJIA on Friday Why Analysts Are Still Chasing Caterpillar Is Southwest Airlines Really Boeing’s Launch Customer for the 737 MAX? Get Quote for: Symbol Lookup Search Why Shares of Norwegian Cruise Line Holdings Ltd. Sank in 2016 Gentex Reflects on a Light Quarter Johnson & Johnson May Never Recoup Its Costs to Buy Actelion Nasdaq Composite advances 0.1% S&P 500 retreats 0.1% Dow slides 0.1% The Zacks Friday Finish Line Highlights: Can Facebook Continue Its Insane Growth? Why MasterCard (MA) May Beat on Earnings in Q4? AstraZeneca's Symbicort Granted Pediatric Exclusivity by FDA U.S. economy slows on wider trade gap; business spending rises Wall Street slips after soft GDP data, earnings Buffett, Gates have hope for America after Trump ascension Gentex Reflects on a Light Quarter Johnson & Johnson May Never Recoup Its Costs to Buy Actelion 3 Quotes from the CEO of Shopify Inc that Every Investor Needs to Read Mark Zuckerberg Listens To Native Hawaiian Concerns, Drops Lawsuits The China-Taiwan Dispute Is Fast Becoming A Divisive Issue In South Africa 50 Groups To Learn About If You’re Committed To Intersectional Feminism Home About Us Disclaimer and Terms of Use Privacy Policy Contact Us Advertise AOL-HuffPost Money & Finance ©2017 24/7 Wall St. | Powered by WordPress.com VIP
